Tyche Industries LtdPharmaceuticalsINE443B01012
Valuation
Market Cap₹117.31 Cr
TTM PE26.74x
Forward PE30.77x
PEG-28.75
Book Value₹190.75
P/B0.60x
TTM EPS₹4.28
Fwd EPS₹3.72
TTM Revenue₹50.04 Cr
TTM PAT₹4.44 Cr
TTM EBITDA₹-1.40 Cr
TTM EBIT₹-3.56 Cr
Last Qtr PAT₹1.15 Cr
Last Qtr EBITDA₹-1.70 Cr
Last Qtr EBIT₹-2.32 Cr
Profitability
ROE
ROCE
TTM NPM8.87%
TTM EBITDA %-2.80%
Curr OPM-0.59%
Last OPM7.13%
Curr NPM
Last NPM
Curr EPS₹-0.04
Last EPS₹1.05
Balance sheet
Equity
Reserve
Total Debt₹0.00 Cr
D/E
Interest %0.00%
Curr Interest₹0.00 Cr
Price / range
Close₹114.45
vs 52W High-22.67%
vs 52W Low+15.61%
MA50
MA200
Returns
1D+3.15%
1W+5.05%
1M+10.05%
3M-10.83%
6M+5.83%
1Y-20.19%
2Y-41.89%
3Y-31.94%
5Y-42.30%
Diwali-0.95%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1868.90₹4.48L Cr150.723.58%
DIVISLAB9410.50₹2.50L Cr84.9417.55%
TORNTPHARM4970.00₹1.89L Cr80.9225.43%
ZYDUSLIFE1161.00₹1.16L Cr33.2412.96%
CIPLA1386.10₹1.12L Cr36.428.93%
LAURUSLABS2017.50₹1.09L Cr124.8516.46%
MANKIND2437.80₹1.01L Cr46.1413.38%
DRREDDY1198.30₹1.00L Cr150.351.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue9.10-28.3%16.2010.5814.1612.7053.63
Other Income2.262.961.852.651.779.22
Total Income11.36-21.5%19.1512.4316.8114.4762.86
Interest000000
Expenditure-11.42-2.0%-17.45-9.97-14.76-11.20-53.39
PBDT000000
EBITDA-1.70-186.7%-0.661.09-0.131.962.24
Depreciation-0.62-0.59-0.48-0.47-0.46-2
EBIT-2.32-254.7%-1.250.61-0.601.500.24
PBT-0.05-101.5%1.702.462.053.269.46
Tax0.01-0.54-0.64-0.53-0.80-2.53
Equity000000
OPM-0.5910.4823.2414.4725.6715.00
Net Profit-0.05-102.1%1.151.821.522.436.94
NPM-0.597.1317.2210.7619.1411.00
EPS-0.041.051.781.4906.70

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue53.63-18.1%65.47-5.8%69.51-7.8%75.39+21.1%62.27-20.4%78.24
Other Income9.227.425.924.834.164.74
Total Income62.86-13.8%72.89-3.4%75.43-6.0%80.21+20.8%66.42-20.0%82.98
Expenditure-53.39+4.8%-56.10+4.6%-58.81+3.6%-61.01-14.9%-53.10+3.9%-55.26
Interest000000
PBDT000000
EBITDA2.24-80.3%11.36-10.1%12.64-21.7%16.15+47.4%10.96-55.6%24.70
Depreciation-2-1.99-1.94-1.77-1.79-1.72
EBIT0.24-97.4%9.37-12.4%10.70-25.6%14.38+56.8%9.17-60.1%22.98
PBT9.46-43.4%16.71+0.5%16.63-12.8%19.08+51.1%12.63-52.8%26.74
Tax-2.53-4.30-4.39-4.91-3.30-6.75
Equity000000
OPM (%)15.0023.0022.0024.0019.0032.00
Net Profit6.94-44.4%12.49+2.0%12.24-13.6%14.17+51.9%9.33-53.3%19.98
NPM (%)11.0017.0016.0018.0014.0024.00
EPS (Rs)6.70-45.0%12.19+3.5%11.78-14.3%13.74+49.8%9.17-52.6%19.35
CEPS6.7012.1911.7813.749.1719.35

Consolidated

0 lines · 0 periods

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

0 lines · 0 years

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

18
YearTypeAmountEx-Date
2025Final Dividend319 Sep 2025
2024Final Dividend2.520 Sep 2024
2023Final Dividend222 Aug 2023
2022Final Dividend1.522 Sep 2022
2021Final Dividend122 Sep 2021
2020Final Dividend122 Sep 2020
2019Final Dividend0.520 Sep 2019
2018Final Dividend0.519 Sep 2018
2017Final Dividend0.521 Sep 2017
2016Final Dividend0.522 Sep 2016
2015Final Dividend0.523 Sep 2015
2014Final Dividend0.525 Sep 2014
2013Final Dividend0.519 Sep 2013
2012Final Dividend0.524 Sep 2012
2011Final Dividend0.523 Sep 2011
2010Final Dividend0.522 Oct 2010
2009Final Dividend0.524 Sep 2009
2008Final Dividend0.524 Sep 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers